Literature DB >> 26893863

A rare case of oligoastrocytoma with atypical symptoms initially diagnosed as multiple sclerosis: A case report.

Jiguo Gao1, Yanli Ti1, Hongmei Meng1, Teng Zhao1, Chunkui Zhou1, Lijun Zhu2, Shaokuan Fang1.   

Abstract

Oligoastrocytoma (OA) is an extremely rare tumor that may be difficult to diagnose, as it mimics multiple sclerosis (MS) clinically and radiologically. OA and MS are both space-occupying lesions. The symptoms of OA are complex and depend on tumor location and size. The clinical symptoms of OA are frequently not typical of glioma; therefore, OA is associated with a high misdiagnosis rate. We herein share our experience with diagnosing a rare OA case with atypical symptoms, which was initially diagnosed as MS, while stereotactic biopsy provided the final diagnosis. Due to the rarity and high misdiagnosis rate of OAs, it is suggested that clinical physicians update their knowledge regarding brain tumor classification and increase their awareness of rare tumor occurrence.

Entities:  

Keywords:  biopsy; glioma markers; immunohistochemistry; multiple sclerosis; oligoastrocytoma

Year:  2015        PMID: 26893863      PMCID: PMC4734078          DOI: 10.3892/mco.2015.686

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  6 in total

1.  Quantification of microheterogeneity in glioblastoma multiforme with ex vivo high-resolution magic-angle spinning (HRMAS) proton magnetic resonance spectroscopy.

Authors:  L L Cheng; D C Anthony; A R Comite; P M Black; A A Tzika; R G Gonzalez
Journal:  Neuro Oncol       Date:  2000-04       Impact factor: 12.300

Review 2.  Low-grade gliomas.

Authors:  Jimmy Ruiz; Glenn J Lesser
Journal:  Curr Treat Options Oncol       Date:  2009-04-19

3.  Differentiation between oligodendroglioma genotypes using dynamic susceptibility contrast perfusion-weighted imaging and proton MR spectroscopy.

Authors:  S Chawla; J Krejza; A Vossough; Y Zhang; G S Kapoor; S Wang; D M O'Rourke; E R Melhem; H Poptani
Journal:  AJNR Am J Neuroradiol       Date:  2013-01-31       Impact factor: 3.825

4.  New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cancer Brain Tumour Group Study 26951.

Authors:  Thierry Gorlia; Jean-Yves Delattre; Alba A Brandes; Johan M Kros; Martin J B Taphoorn; Mathilde C M Kouwenhoven; H J J A Bernsen; Marc Frénay; Cees C Tijssen; Denis Lacombe; Martin J van den Bent
Journal:  Eur J Cancer       Date:  2013-07-26       Impact factor: 9.162

Review 5.  The 2007 WHO classification of tumours of the central nervous system.

Authors:  David N Louis; Hiroko Ohgaki; Otmar D Wiestler; Webster K Cavenee; Peter C Burger; Anne Jouvet; Bernd W Scheithauer; Paul Kleihues
Journal:  Acta Neuropathol       Date:  2007-07-06       Impact factor: 17.088

6.  Temozolomide salvage chemotherapy for recurrent anaplastic oligodendroglioma and oligo-astrocytoma.

Authors:  Ho-Shin Gwak; Gi Taek Yee; Chul-Kee Park; Jin Wook Kim; Yong-Kil Hong; Seok-Gu Kang; Jeong Hoon Kim; Ho Jun Seol; Tae-Young Jung; Jong Hee Chang; Heon Yoo; Jeong-Hyun Hwang; Se-Hyuk Kim; Bong Jin Park; Sun-Chul Hwang; Min Su Kim; Seon-Hwan Kim; Eun-Young Kim; Ealmaan Kim; Hae Yu Kim; Young-Cho Ko; Hwan Jung Yun; Ji Hye Youn; Juyoung Kim; Byeongil Lee; Seung Hoon Lee
Journal:  J Korean Neurosurg Soc       Date:  2013-12-31
  6 in total
  1 in total

Review 1.  Multiple cerebral gliomas mimicking central nervous system inflammatory demyelinating diseases: A rare case with review of literature.

Authors:  Yong-Jie Xiong; Xin-Ling Zhao; Xiao-Yan Wang; Deng-Ji Pan; Dai-Shi Tian
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.889

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.